About this trial
The study will involve boys with Duchenne Muscular Dystrophy (DMD), from adolescence to adulthood living in Italy, and their families/ caregivers.
The Investigators want to explore patients' mental health, social cognition and perception of body image as well as patients'and caregivers' ability to adapt to changes related to both the disease and various personal and social needs, through the use of short and simple questionnaires, neuropsychological tests and neurocognitive evaluation in ecological scenarios using Virtual Reality. The desire for autonomy and the awareness of both personal and social difficulties in achieving them put a strain on both patients and their families.Some studies conducted in the USA and in various European countries underline that the transition to adulthood of patients with muscular dystrophy is featured by a good ability to adapt to the more advanced stages of the disease in general; nevertheless, facing the worsening of health entails experiences of anxiety and depression.In this historical phase, clinical trials of gene therapy and gene modulating therapies are involving an increasing number of patients, mainly represented by children in the early phase of the disease. Hence, adolescents and young adults could develop feelings of exclusion from research efforts, losing confidence and hope in any future improvement of their condition, social participation and quality of life.This study could lead to identify strengths and weaknesses in social cognition and psychosocial adaptation; through the evaluation of characteristics of patients/caregivers or exogenous factors influencing higher levels of social adaptation, we ultimately aim to define strategies to improve not only physical (already defined by guidelines) but also psychological care, social cognition and social support in all stages of DMD, particularly in later ones.
Eligibility criteria
Qualifiers
Defined diagnosis of DMD
Age > 14 years
Willingness and ability to comply to study procedures
Comprehension of the study and Signature of the informed consent
Disqualifiers
Clinical history of cerebral palsy, severe intellectual deficit, severe behavioral disturbances
absence of compliance to the studyof the patient and the caregivers.
Trial design
Treatments tested in this trial
- VIRTUAL REALITY
Treatment groups
Sponsors and collaborators
IRCCS Eugenio Medea
Lead sponsor
University of Padova
Collaborator
IRCCS National Neurological Institute "C. Mondino" Foundation
Collaborator
Istituto Giannina Gaslini - IRCCS
Collaborator
Fondazione Serena Onlus - Centro Clinico NeMO Milano
Collaborator
Centro Clinico NeMO Ancona
Collaborator
IRCCS Fondazione Stella Maris
Collaborator
Università degli Studi di Milano Statale
Collaborator
Centro Clinico NeMO Brescia
Collaborator
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Collaborator
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborator
I.R.C.C.S. Eugenio Medea - Associazione La Nostra Famiglia - Sede di Conegliano
Collaborator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborator
Dipartimento di Neuroscienze Rita Levi Montalcini Torino
Collaborator
Università Vita-Salute San Raffaele
Collaborator
Università di Pisa
Collaborator
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Collaborator
Associazione La Nostra Famiglia Eugenio Medea - Brindisi
Collaborator
Scientific Institute, IRCCS E.Medea, Pasian di Prato
Collaborator
IRCCS Istituto delle Scienze Neurologiche di Bologna
Collaborator